Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic LeukemiaWilliam G. Wierda, Anders Österborg, Stephan Stilgenbauer et al.|Journal of Clinical Oncology|2010Cited by 587